2021 American Transplant Congress
Results of Litmus (nct 02541916): The Liver Immune Tolerance Bio Marker Utilization Study
*Purpose: Although it is known that some liver transplant recipients are operationally tolerant and can be weaned off immunosuppression (IS), there is not currently a…2021 American Transplant Congress
Biliary Complications Following Adult Deceased Donor Liver Transplantation: Risk Factors and Implications at a High-Volume US Center
Emory Transplant Center, Atlanta, GA
*Purpose: Biliary leaks and anastomotic strictures comprise the majority of biliary complications (BCs) following liver transplantation. Most case series of BCs in adult deceased donor…2021 American Transplant Congress
Implementation of a High-risk Medication Report for Waitlisted Liver Transplant Candidates
1Pharmacy, Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Boston, MA
*Purpose: Use of high-risk medications (HRMs) at the time of liver transplant may lead to delays in surgery or peri-operative complications (bleeding, drug-drug interactions (DDI),…2021 American Transplant Congress
Admission to the Intensive Care Unit Post-liver Transplantation: One Academic Center’s Experience
Transplant Critical Care, Mayo Clinic, Jacksonville, FL
*Purpose: Historically, liver transplant (LT) patients have been admitted directly from the operating room (OR) to the intensive care unit (ICU) for post-operative complex hemodynamic…2021 American Transplant Congress
Evaluation of Increasing Liver Discard Rate and Waiting List Drop-Off in Post-MELD Era
*Purpose: As number of donors and transplant cases rises each year, it is important to evaluate not only post-transplant survival rate but also the organ…2021 American Transplant Congress
Impact of Pediatric Living Donor Liver Transplant Center Volume on Waiting List and Post-Transplant Outcomes
*Purpose: The aim of this study was to compare pediatric liver transplant (pLT) waiting list and post-transplant outcomes by center pediatric living donor liver transplant…2021 American Transplant Congress
The Gut Microbiome in Heart Transplantation: A Prospective Pilot Study
*Purpose: The contribution of the intestinal microbiome to alloimmunity in heart transplantation (HT) is unknown. We examined the fecal microbiota of HT recipients at the…2021 American Transplant Congress
Improved Outcomes Over Time of Extended Criteria Donor Grafts for Acute-on-chronic Liver Failure
Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI
*Purpose: Given the high waitlist mortality of patients with acute-on-chronic liver failure (ACLF), liver transplant (LT) with an extended criteria donor (ECD) can be considered.…2021 American Transplant Congress
Pre-Transplant Frailty is Associated with 30-Day Mortality but Not Long-Term Survival After Liver Transplantation
Department of Surgery, University of Michigan Health System, Ann Arbor, MI
*Purpose: Frailty predicts waitlist death in liver transplant (LT) candidates, but the impact of frailty on mortality after LT is unknown. We investigated the association…2021 American Transplant Congress
The Predictive Factors of Survival in Re-listed Patients Who Received Initial Liver Transplants Using Donation After Circulatory Death Grafts
Cleveland Clinic, Cleveland, OH
*Purpose: The inherent risk of livers from donors after circulatory death (DCD) is well known such as primary non-function (PNF) and increased rates of biliary…
- « Previous Page
- 1
- …
- 27
- 28
- 29
- 30
- 31
- …
- 180
- Next Page »